Patents by Inventor Christopher Brian Buck

Christopher Brian Buck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS TO DIAGNOSE AND IMMUNIZE AGAINST THE VIRUS CAUSING HUMAN MERKEL CELL CARCINOMA
    Publication number: 20140037581
    Abstract: The present invention provides isolated or substantially purified polypeptides, nucleic acids, and virus-like particles (VLPs) derived from a Merkel cell carcinoma virus (MCV), which is a newly-discovered virus. The invention further provides monoclonal antibody molecules that bind to MCV polypeptides. The invention further provides diagnostic, prophylactic, and therapeutic methods relating to the identification, prevention, and treatment of MCV-related diseases.
    Type: Application
    Filed: July 26, 2013
    Publication date: February 6, 2014
    Applicants: The United States of America, as Represented by the Secretary, Department of Health and Human Serv, University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: Patrick S. Moore, Yuan Chang, Huichen Feng, Christopher Brian Buck, Diana V. Pastrana
  • Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma
    Patent number: 8524248
    Abstract: The present invention provides isolated or substantially purified polypeptides, nucleic acids, and virus-like particles (VLPs) derived from a Merkel cell carcinoma virus (MCV), which is a newly-discovered virus. The invention further provides monoclonal antibody molecules that bind to MCV polypeptides. The invention further provides diagnostic, prophylactic, and therapeutic methods relating to the identification, prevention, and treatment of MCV-related diseases.
    Type: Grant
    Filed: December 15, 2008
    Date of Patent: September 3, 2013
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Patrick S. Moore, Yuan Chang, Huichen Feng, Christopher Brian Buck, Diana V. Pastrana
  • METHODS TO DIAGNOSE AND IMMUNIZE AGAINST THE VIRUS CAUSING HUMAN MERKEL CELL CARCINOMA
    Publication number: 20110135598
    Abstract: The present invention provides isolated or substantially purified polypeptides, nucleic acids, and virus-like particles (VLPs) derived from a Merkel cell carcinoma virus (MCV), which is a newly-discovered virus. The invention further provides monoclonal antibody molecules that bind to MCV polypeptides. The invention further provides diagnostic, prophylactic, and therapeutic methods relating to the identification, prevention, and treatment of MCV-related diseases.
    Type: Application
    Filed: December 15, 2008
    Publication date: June 9, 2011
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, The U.S.of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Patrick M. Moore, Yuan Chang, Huichen Feng, Christopher Brian Buck, Diana V. Pastrana